|
1
|
Graham DY: Helicobacter pylori update:
Gastric cancer, reliable therapy, and possible benefits.
Gastroenterology. 148:719–31. e32015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamashima C, Shabana M, Okada K, Okamoto M
and Osaki Y: Mortality reduction from gastric cancer by endoscopic
and radio-graphic screening. Cancer Sci. 106:1744–1749. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al CONCORD Working Group: Global surveillance of cancer survival
1995-2009: Analysis of individual data for 25,676,887 patients from
279 population-based registries in 67 countries (CONCORD-2).
Lancet. 385:977–1010. 2015. View Article : Google Scholar
|
|
4
|
Oliveira C, Pinheiro H, Figueiredo J,
Seruca R and Carneiro F: Familial gastric cancer: Genetic
susceptibility, pathology, and implications for management. Lancet
Oncol. 16:e60–e70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garajová I, Ferracin M, Porcellini E,
Palloni A, Abbati F, Biasco G and Brandi G: Non-coding RNAs as
predictive biomarkers to current treatment in metastatic colorectal
cancer. Int J Mol Sci. 18:15472017. View Article : Google Scholar :
|
|
6
|
Pop-Bica C, Gulei D, Cojocneanu-Petric R,
Braicu C, Petrut B and Berindan-Neagoe I: Understanding the role of
non-coding RNAs in bladder cancer: From dark matter to valuable
therapeutic targets. Int J Mol Sci. 18:15142017. View Article : Google Scholar :
|
|
7
|
Hao NB, He YF, Li XQ, Wang K and Wang RL:
The role of miRNA and lncRNA in gastric cancer. Oncotarget.
8:81572–81582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chandra S, Vimal D, Sharma D, Rai V, Gupta
SC and Chowdhuri DK: Role of miRNAs in development and disease:
Lessons learnt from small organisms. Life Sci. 185:8–14. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhan JW, Jiao DM, Wang Y, Song J, Wu JH,
Wu LJ, Chen QY and Ma SL: Integrated microRNA and gene expression
profiling reveals the crucial miRNAs in curcumin anti-lung cancer
cell invasion. Thorac Cancer. 8:461–470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang WC, Ren JL, Wong CW, Chan SO, Waye
MM, Fu WM and Zhang JF: lncRNA-NEF antagonized epithelial to
mesenchymal transition and cancer metastasis via cis-regulating
FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene.
37:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Y, Huang W, Sun W, Zheng B, Wang C,
Luo Z, Wang J and Yan W: lncRNA MALAT1 promotes cancer metastasis
in osteosarcoma via activation of the PI3K-Akt signaling pathway.
Cell Physiol Biochem. 51:1313–1326. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen G, Cao Y, Zhang L, Ma H, Shen C and
Zhao J: Analysis of long non-coding RNA expression profiles
identifies novel lncRNA biomarkers in the tumorigenesis and
malignant progression of gliomas. Oncotarget. 8:67744–67753.
2017.PubMed/NCBI
|
|
13
|
Cao MX, Jiang YP, Tang YL and Liang XH:
The crosstalk between lncRNA and microRNA in cancer metastasis:
Orchestrating the epithelial-mesenchymal plasticity. Oncotarget.
8:12472–12483. 2017.
|
|
14
|
Li P, Tong L, Song Y, Sun J, Shi J, Wu Z,
Diao Y, Li Y and Wang Z: Long noncoding RNA H19 participates in
metformin-mediated inhibition of gastric cancer cell invasion. J
Cell Physiol. 234:4515–4527. 2019. View Article : Google Scholar
|
|
15
|
Collette J, Le Bourhis X and Adriaenssens
E: Regulation of human breast cancer by the long non-coding RNA
H19. Int J Mol Sci. 18:23192017. View Article : Google Scholar :
|
|
16
|
Huang Z, Lei W, Hu HB, Zhang H and Zhu Y:
H19 promotes non-small-cell lung cancer (NSCLC) development through
STAT3 signaling via sponging miR-17. J Cell Physiol. 233:6768–6776.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li CF, Li YC, Wang Y and Sun LB: The
effect of lncRNA H19/miR-194-5p axis on the epithelial-mesenchymal
transition of colorectal adenocarcinoma. Cell Physiol Biochem.
50:196–213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhuang M, Gao W, Xu J, Wang P and Shu Y:
The long non-coding RNA H19-derived miR-675 modulates human gastric
cancer cell proliferation by targeting tumor suppressor RUNX1.
Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jafarzadeh-Samani Z, Sohrabi S,
Shirmohammadi K, Effatpanah H, Yadegarazari R and Saidijam M:
Evaluation of miR-22 and miR-20a as diagnostic biomarkers for
gastric cancer. Linchuang Zhongliuxue Zazhi. 6:162017.
|
|
20
|
Li B, Li B, Sun H and Zhang H: The
predicted target gene validation, function, and prognosis studies
of miRNA-22 in colorectal cancer tissue. Tumour Biol.
39:10104283176922572017.PubMed/NCBI
|
|
21
|
Chen J, Wu FX, Luo HL, Liu JJ, Luo T, Bai
T, Li LQ and Fan XH: Berberine upregulates miR-22-3p to suppress
hepatocellular carcinoma cell proliferation by targeting Sp1. Am J
Transl Res. 8:4932–4941. 2016.PubMed/NCBI
|
|
22
|
Lv KT, Liu Z, Feng J, Zhao W, Hao T, Ding
WY, Chu JP and Gao LJ: miR-22-3p regulates cell proliferation and
inhibits cell apoptosis through targeting the eIF4EBP3 gene in
human cervical squamous carcinoma cells. Int J Med Sci. 15:142–152.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin M, Qiao Z, Li J, Liu J, Song S, Zhao
X, Miao P, Tang T, Wang L, Liu W, et al: miR-22 inhibits tumor
growth and metastasis by targeting ATP citrate lyase: Evidence in
osteo-sarcoma, prostate cancer, cervical cancer and lung cancer.
Oncotarget. 7:44252–44265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Zou M, Li J, Wang B, Zhang Q, Liu
F and Lü G: lncRNA H19 targets miR-22 to modulate
H2O2-induced deregulation in nucleus pulposus
cell senescence, proliferation, and ECM synthesis through Wnt
signaling. J Cell Biochem. 119:4990–5002. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-∆ ∆ C (T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
26
|
Gooding AJ, Zhang B, Jahanbani FK, Gilmore
HL, Chang JC, Valadkhan S and Schiemann WP: The lncRNA BORG drives
breast cancer metastasis and disease recurrence. Sci Rep.
7:126982017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu H, Hu Y, Liu X, Song W, Gong P, Zhang
K, Chen Z, Zhou M, Shen X, Qian Y, et al: lncRNA TRERNA1 function
as an enhancer of SNAI1 promotes gastric cancer metastasis by
regulating epithelial-mesenchymal transition. Mol Ther Nucleic
Acids. 8:291–299. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao L, Han T, Li Y, Sun J, Zhang S, Liu
Y, Shan B, Zheng D and Shi J: The lncRNA SNHG5/miR-32 axis
regulates gastric cancer cell proliferation and migration by
targeting KLF4. FASEB J. 31:893–903. 2017. View Article : Google Scholar
|
|
29
|
Lü MH, Tang B, Zeng S, Hu CJ, Xie R, Wu
YY, Wang SM, He FT and Yang SM: Long noncoding RNA BC032469, a
novel competing endogenous RNA, upregulates hTERT expression by
sponging miR-1207-5p and promotes proliferation in gastric cancer.
Oncogene. 35:3524–3534. 2016. View Article : Google Scholar
|
|
30
|
Xu TP, Liu XX, Xia R, Yin L, Kong R, Chen
WM, Huang MD and Shu YQ: SP1-induced upregulation of the long
noncoding RNA TINCR regulates cell proliferation and apoptosis by
affecting KLF2 mRNA stability in gastric cancer. Oncogene.
34:5648–5661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan J, Zhang Y, She Q, Li X, Peng L, Wang
X, Liu S, Shen X, Zhang W, Dong Y, et al: Long Noncoding RNA
H19/miR-675 axis promotes gastric cancer via FADD/caspase 8/caspase
3 signaling pathway. Cell Physiol Biochem. 42:2364–2376. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu G, Xiang T, Wu QF and Wang WX: Long
noncoding RNA H19-derived miR-675 enhances proliferation and
invasion via RUNX1 in gastric cancer cells. Oncol Res. 23:99–107.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu Q, Yin J, Zeng A, Jin X, Zhang Z, Yan W
and You Y: H19 functions as a competing endogenous RNA to regulate
EMT by sponging miR-130a-3p in glioma. Cell Physiol Biochem.
50:233–245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vennin C, Spruyt N, Dahmani F, Julien S,
Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and
Adriaenssens E: H19 non coding RNA-derived miR-675 enhances
tumorigenesis and metastasis of breast cancer cells by
downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu J, Huang Y, Wu Y, Liu F, Sun D, Wang K
and Qu H: NTRK2 is an oncogene and associated with microRNA-22
regulation in human gastric cancer cell lines. Tumour Biol.
37:15115–15123. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zuo QF, Cao LY, Yu T, Gong L, Wang LN,
Zhao YL, Xiao B and Zou QM: MicroRNA-22 inhibits tumor growth and
metastasis in gastric cancer by directly targeting MMP14 and Snail.
Cell Death Dis. 6:e20002015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou LH, Yang YC, Zhang RY, Wang P, Pang
MH and Liang LQ: CircRNA_0023642 promotes migration and invasion of
gastric cancer cells by regulating EMT. Eur Rev Med Pharmacol Sci.
22:2297–2303. 2018.PubMed/NCBI
|
|
38
|
Xiang Z, Jiang DP, Xia GG, Wei ZW, Chen W,
He Y and Zhang CH: CXCL1 expression is correlated with Snail
expression and affects the prognosis of patients with gastric
cancer. Oncol Lett. 10:2458–2464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao J, Yang C, Guo S and Wu Y: GM130
regulates epithelial- to-mesenchymal transition and invasion of
gastric cancer cells via snail. Int J Clin Exp Pathol.
8:10784–10791. 2015.
|
|
40
|
Zhang J, Zhou Y and Yang Y: CCR7 pathway
induces epithelial-mesenchymal transition through up-regulation of
Snail signaling in gastric cancer. Med Oncol. 32:4672015.PubMed/NCBI
|
|
41
|
Feng Y, Sun T, Yu Y, Gao Y, Wang X and
Chen Z: MicroRNA-370 inhibits the proliferation, invasion and EMT
of gastric cancer cells by directly targeting PAQR4. J Pharmacol
Sci. 138:96–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
